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Partial cloning and characterization of an arginine decarboxylase in
the kidney. Using homology-based polymerase chain reaction (PCR)
amplification, we demonstrate the presence of arginine decarboxylase
mRNA in tissues involved in arginine metabolism (brain, kidney, gut,
adrenal gland, and liver of the rat) but not in organs (lung, heart, and
spleen) in which arginine metabolism is low or absent. The polymerase
chain reaction product from the kidney had a nucleotide sequence 61%
identical to that of the E. coli biosynthetic arginine decarboxylase. On a
whole tissue basis, kidney homogenates were three times more active than
brain homogenates at decarboxylating [1-14C]arginine. Subcellular frac-
tionation localized the arginine decarboxylase activity of the kidney to the
mitochondria fraction. Agmatine, one of the products of arginine decar-
boxylation, was found to inhibit nitric oxide formation by post-mitochon-
drial supernatants of the brain or kidney. We propose that arginine is
metabolized to two structurally different signaling molecules, nitric oxide
and agmatine. Furthermore, agmatine can influence the nitric oxide
synthase pathway.
L-arginine is essential for the synthesis of urea, creatine and
nitric oxide [1], in addition to its role in protein synthesis. A novel
metabolic pathway resulting in decarboxylation of L-arginine and
formation of agmatine has been described in the brain [21.
Agmatine, a "clonidine-displacing substance," can bind to both a2
adrenergic and imidazoline-guanidinium receptor sites (IGRS),
with a wide variety of biologic effects [2]. Clonidine-displacing
substance is present in peripheral tissues and circulation of the rat
[3], and is increased in the serum of some patients with pregnancy-
induced hypertension [4]. The IGRS of proximal tubule basolat-
eral membranes recognize clonidine displacing substance [5, 6].
Agmatine synthesis depends on the presence of an L-arginine
decarboxylase (E.C. 4.1.1.19); however, an mRNA for this enzyme
has not been described in mammalian cells [7]. In this investiga-
tion, we used homology-based PCR amplification to uncover an
arginine decarhoxylase mRNA in several tissues of the rat.
Methods
Measurement of arginine decarboxylation
The production of labeled CO2 from [1-(14C)Jarginine was
determined essentially as described [2]. Briefly, whole rat kidney
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or manually dissected kidney cortex, outer and inner stripe of the
kidney outer and inner medulla or whole rat brain were homog-
enized in 3 volumes (wt/vol) of ice-cold 5 mivi Tris chloride, pH
8.8, 0.8 m magnesium sulfate. In some experiments the cortex
was separated into glomeruli and tubules by sieving [81 prior to
homogenization. The protein content of each homogenate was
determined by the method of Bradford [9]. Preliminary studies
revealed that [14C]-C02 formation was linear with time through at
least 90 minutes of incubation, in each case the activity of a boiled
(microwaved) enzyme blank was subtracted. This activity usually
amounted to about 10 to 15 pmollhr/mg protein.
Subcellular fractionation of kidney
Rat kidney cortex was homogenized with 6 volumes (wt/vol) of
ice-cold 0,25 M sucrose, 25 mrvt Tris chloride pH 7.4 and 0.1 mM
phenyl methyl sulfonyifluoride. The homogenate was filtered
through four layers of gauze followed by centrifugation at 500 X g
for 10 minutes. This supernatant was further centrifuged at 30,000
Xg for 20 minfites. In other experiments, the 500 Xg supernatant
was first centrifuged at 7,500 or 10,000 Xg for 10 minutes followed
by 30,000 Xg for 20 minutes. The different pellets of membrane
protein were resuspended in 5 mrvi Tris chloride pH 8.8, 0.8 mM
magnesium sulfate prior to assay. The activity of succinate dehy-
drogenase in the various fractions of the kidney was measured
using triphenyltetrazolium chloride as described previously [10].
Measurement of nitric oxide synthase activity
The production of labeled citrulline from [U(14C)]arginine was
determined essentially as described [11, 12]. Briefly, whole rat
cerebellum or kidney cortex was homogenized in 0.32 M sucrose,
50 mM Tris chloride, 1 mr't EDTA, 1 m dithiothreitol, 100 .tg/ml
phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 2 j.tg/ml apro-
tinin pH 7 [12]. A post-mitochondrial (7,500 Xg) supernatant was
added to a buffer consisting of 50 m potassium phosphate, 60
mM valine, 120 LM NAPDH, 1 mivi L-citrulline, 25 .LM L-arginine,
1.2 m magnesium chloride, 0.25 m calcium chloride and 0.075
pCi L-[(U)'4C]arginine pH 7.2 with or without 1 mM N'°-nitro-L-
arginine methylester (L-NAME). The reaction was incubated at
37°C for 10 minutes. The amount of ['4C1 citrulline formed was
determined by dilution of the reaction mix with 4 ml of water and
1 ml of a 1:1 (vol/vol) mix. of water with Dowex-50WX8 (200 to
400 mesh) in the sodium form. Two milliliters of the aqueous
supernatant were used for liquid scintillation determination of
radioactivity [11]. The amount of agmatine added to the reaction
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mix did not influence the binding of labeled arginine to the ion
exchange resin (not shown).
Amplification of arginine decarboxylase mRNA
Female Sprague-Dawley rats (Harlan, Indianapolis, IN, USA)
were used throughout the study. Rats were fed a standard rat
chow (Purina, St. Louis, MO, USA). Single strand oligo dT-
primed cDNA libraries were prepared from the kidney, brain,
liver, gut, lung, heart, spleen and adrenal gland of the rat as
described [8]. Primers for the homology-based amplification of
putative arginine decarboxylase mRNA were selected by compar-
ing the sequence of the E. co/i biosynthetic [13] and the oat (A.
Sativa) [14] enzymes. The primer pairs consisted of sense (GGG
CTG GAG GCA GGC TCC AAG CCA GAG TTG), represent-
ing amino acids 125-134, and antisense (GGA GCC GAC GTG
GAA GTG CAG CAG), representing amino acids 249-256 of oat
arginine decarboxylase [14]. Amplification was performed with
cDNA using 35 cycles of denaturation at 94°C for one minute and
annealing at 60°C for one minute followed by extension at 72°C
for two minutes, The amount of the arginine decarboxylase cDNA
determined by PCR was normalized by the amount of glyceralde-
hyde phosphate dehydrogenase (GAPDH) cDNA also deter-
mined by PCR, but using only 28 cycles [81. This number of cycles
allowed for the relative assessment of the amount of GAPDH
cDNA and arginine decarboxylase eDNA. The products were
separated by means of 1% agarose gels (Fisher Scientific, Fair
Lawn, NJ, USA) in 40 M Tris acetate, 2.5 m ethylene diaminetet-
raacetic acid buffer pH 8.0 containing ethidium bromide. The
product for arginine decarboxylase migrated at 387 bp while the
GAPDH product migrates at 515 bp.
Sequence of arginine decarboxylase
The 387 bp PCR product arising from the amplification of
kidney eDNA using the primers for arginine decarboxylase was
sequenced by two techniques. One utilized a Femtomole sequenc-
ing kit (Promega, Madison, WI, USA), while the other required
ligation of the product into the vector pCRII (Invitrogen, San
Diego, CA, USA). The protocol for dideoxy sequencing with
7-deaza guanosine supplemented reaction mixes was as described
previously [8]. The final sequence reported here was a consensus
of several sequencing reactions performed on three independently
purified arginine decarboxylase DNA containing plasmids.
Results and discussion
To identify the presence of arginine decarboxylase mRNA in
different tissues of the rat, we used oligonucleotide primers to
conserved regions of the E. co/i and oat enzymes—which, in turn,
flanked conserved regions—and this disclosed a product of ex-
pected size. All results were normalized for the relative amount of
glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA. The
whole kidney contained considerably more mRNA for arginine
decarboxylase than other tissues (Fig. 1). Appreciable amounts of
arginine decarboxylase cDNA were also found in the brain, liver,
gut and adrenal gland (Fig. 1). Undetectable to barely detectable
amounts of the arginine decarboxylase mRNA were found in
organs with low or absent arginine metabolism (lung, heart and
spleen). The amplification of the GAPDH cDNA had been
stopped at cycle 28, which, as shown in preliminary studies, is in
the quantitative range prior to plateauing of product formation.
Similarly, the arginine decarboxylase cDNA amplification was
Fig. 1. Polymerase chain reaction amplification of aiginine decarboxylase.
Represented are: brain, lane 2; kidney, lane 3; liver, lane 4; gut, lane 5;
lung, lane 6; heart, lane 7; spleen, lane 8; and adrenal gland, lane 9. Single
strand eDNA was amplified for arginine decarboxylase (A) or UAPDH
(B). Lanes 1 and 10 represent sizing markers while lane 11 of A represents
the arginine decarboxylase amplification mix without added eDNA.
stopped at cycle 35. The consistent finding when tissues from
several different animals were analyzed was that the kidney had a
higher amount of putative arginine decarboxylase mRNA than
found in the other tissues examined under these conditions. At the
least this survey identifies tissues that contain arginine decarbox-
ylase mRNA.
The PCR product from the kidney was cloned and the DNA
sequence determined. The nucleotide sequence of this product
was 61% and 47% identical to theE. co/i biosynthetic [131 and oat
[14] sequences, respectively (Fig. 2). There was 56% and 49%
conservation of the amino acid sequence compared to the E. co/i
biosynthetic and oat enzymes. Our partial sequence is equivalent
to amino acids 146-275 of the E. co/i enzyme [13] and 125-256 of
the A. Sativa enzyme [14]. The rat kidney arginine decarboxylase
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CCC GTC CTC ACC CCT TGC CTC AAC
--A --A --G G-A -A- GCT CGC -T-
ATT -
-C A-G AG- TCC -TC AC- AAA GCC
ATC GTC TGC AAC GGC TAC AAA GAC CGC GAG TTC ATC CGC GTG CCC
GTC T --T A -AT A
CCC TAC C-G - -A G - - - TCG -CT -AT C- - CCC - -C - -C
TCC
--G
Fig. 2. Nucleotide sequence of rat kidney alginine decarboxylase. The sequence of the PCR amplified arginine decarboxylase is compared to the
nucleotide sequence of the E. coli biosynthetic [131 and the oat (A. Sativa) [141 enzymes. The numbers in the left margin refer to the positions within
the respective sequence. A hyphen (-) indicates the same niicleotide as in the rat sequence; a space indicates a deletion in the sequence. Underlining
indicates the primer regions used in the amplification.
Table 1. Arginine decarboxylase activity of rat brain and kidney
Activity
Tissue pmol C02/hr!mglprotein
Whole brain 74 3
Whole kidney 245 21, P < 0.004
Kidney cortex 199 38
Glomeruli 41 2
Tubules 165 24, P < 0.02
Kidney outer medulla
Outer stripe 240 70
Inner stripe 184 18
Kidney Inner Medulla Not greater than blank values
Values shown are the mean SD of three separate determinations. A
heat-inactivated blank "activity" was routinely subtracted from each value.
This blank usually amounted to 10 to 15 pmol/hr/mg protein.
was not found to be homologous to the E. co/i biodegradative
enzyme [15].
We also examined the liberation of {14C1-C02 from labeled
arginine by tissue homogenates. We found that under identical
isolation and assay conditions whole kidney homogenates liberate
about threefold more labeled CO2 from C-i labeled arginine than
whole brain homogenates (Table 1), when normalized for the
amount of total protein.
The arginine decarboxylase activity in different regions of the
kidney was measured. On a total protein basis both the outer and
inner stripe of the outer medulla had greater decarboxylase
activity than the cortex (Table 1). The inner medulla had no
demonstrable activity above the heat inactivated tissue blank. If
the cortex was mechanically separated (sieved) into glomeruli and
tubules, the decarboxylase activity of the cortex was present








Homogenate 206 38 0
30,000 Xg supernatant 83 4 0.07 0.02
500—30,000 Xg pellet 1364 32 3.09 0.42
500—7,500 Xg pellet 1545 105 7.10 0.82
7,500—30,000 xg pellet 21 4 1.07 0.75
Values shown are the mean SD of three separate determinations. The
succinate dehydrogenase enrichments were calculated setting the activity
of the homogenate at 1.0.
mainly in the tubules, with about 20% of the activity present in the
glomeruli (Table 1).
Using differential centrifugation of kidney homogenates, we
found that the activity of the arginine decarboxylase was located
mainly, if not exclusively, in the membrane fraction of the cell.
Within this membrane fraction the activity was located in the 500
to 7,500 Xg fraction, which is enriched in mitochondria based
upon the enrichment of the enzyme succinate dehydrogenase
(Table 2).
In further studies we determined that agmatine affects the
formation of nitric oxide in post-mitochondrial supernatants of
cerebellum or kidney cortex. These are sources of constitutive
nitric oxide synthase [12]. Agmatine at millimolar concentrations
inhibited nitric oxide synthase activity as measured by the conver-
sion of radiolabeled arginine to radiolabeled citrulline (Table 3).
The synthase activity measured was found to be calcium-depen-













GGG CTG GAG GCA CGC TCC AAG CCA GAG TTC CTG




CTC ATG CCC CAC AAC CTG GGC CAC AAC GTC TTG ATC GTG ATC GAG AAA GAG TCC GAG GTG
T-A --T --- C A-- --C C --C -AT C-G --C --T C AT- --A --A A-C
CC- -CC -CC CCC A C A C-C GAG --- C--
CCC CTG GTG ATC GAA GAG CCC CCC GAG CTG AAG GTC AAC CCC GAG GTC CCC CTC CGT GTC
--CA-T --- C-C --T --A --A -AACCT T --- GTT --T -GTC-G --- C GA
-AC A-C TCC C --- AG- AG- A-C --C GGC --G C-- --C GTC A C-C --C -CC
CCC CTG TCC TCG CTG GCT TCC ACC AAC TAG TCC CAT ACC GOT CCC GAG AAG TCC AAG GTC
CCT G-T --A -C- CACTCGT-- --C --C --A --A --C --- T--
AAG - - - CTC A-C AA- ATA C- - C- - C-T -TT CCC TCG - -G -CC - - - A- - C-C CGT - - - T--
CCC CTC TCG CCT ACC GAG TTG TTA TCG GTG GTC GAG CGC ATC CCC ATA GCA AGC CTC GAG
--C -CT --- C-A C-C CAA C-- --G C-A AC- C-C --T GA- --C G-G -CT CT-
-
-G --A C-- --C GAG A-- A-T -AT GA C- A-- MG C-- AAC GCT CTG -A- AA- CTG
GAG CCC ATC CCC CTG CTG GAG TTC CAC GTC CCC
C-C A-- C-C -AA - -A C-- --T
C-T T-C C- - AAG
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Activity
Tissue Condition pmol citndline/min/mg protein
Cerebellum
The values given represent the mean SD of three separate determi-
nations normalized for the amount of protein.
Thus, in the rat kidney arginine can be decarboxylated to
produce agmatine. The physiological role of agmatine as a
signaling molecule in the different tissues with arginine decarbox-
ylase activity (brain, kidney, liver, gut and adrenal gland) remains
to be defined. Metabolism of L-arginine through this pathway may
influence the activity of the nitric oxide pathway. Indeed, agma-
tine inhibits constitutive nitric oxide synthase activity (present
investigation) and the presumed inducible enzyme [16]. Nitric
oxide inhibits mitochondrial respiratory chain enzymes [17].
Therefore, agmatine production by the mitochondria could serve
as a protective mechanism against cytotoxicity from excessive
nitric oxide formation. Although this inhibition in vitro is in the
millimolar range, it is not known what concentrations of agmatine
may be achieved in vivo.
It is likely that kidney function(s) influenced by a2-adrenergic
or IGRS are modulated by locally produced (renal cells) agma-
tine. Clonidine displacing substance has a higher affinity (about
24-fold) for the IGRS than the cs2-adrenergic receptor on renal
cortical membranes [17]. Of interest is the fact that mitochondrial
outer membranes contain a significant number of IGRS which do
not appear to influence oxidative phosphorylation, however [18].
The Na/H exchange activity of proximal tubule cells is inhibited
by compounds that bind to the IGRS [19] but is stimulated
through the a2 adrenergic receptor [20]. Defining the effects of
agmatine on kidney function, therefore, awaits further studies.
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